ANNUAL MEETING '21 | DENVER, CO
The buttons below are links to the most commonly requested information. Please complete the Travel Expense Form if you have reimbursable travel expenses. And for CE information, evaluations, and additional conference materials, please click on the Whova App button.
Note: you may have to search "AVAHO 2021" in your events on the app, as it is a past event.
How to Get Your CE Certificate
- Go to http://AVAHO.cmecertificateonline.com
- Click on the “24.21 Annual Meeting” link.
- Evaluate the meeting.
- Print all pages of your certificate for your records.
Questions? Email Certificate@AmedcoEmail.com
Have follow-up questions? Contact Us!
Sue Lentz, Administrator
admin@avaho.org
Julie Lawson, Executive Director
execdirector@avaho.org
Heather Roderick, Meeting Planner
admin@avaho.org
Check out our Program Agenda
Loading...
What you need to know
Due to concerns about the pandemic and keeping our members and partners safe, the AVAHO board has made the tough decision to limit the number of members that can attend the meeting in Denver. There are no restrictions on virtual attendance.
REGISTRATION
Only current AVAHO members can attend (limited to 250)
You must have your 2021 dues paid prior to registration
Your registration will be reviewed and once approved, you will receive further instructions on travel
Only those with badges will be allowed to participate in AVAHO activities
We will livestream some of the sessions for our virtual attendees. There will be virtual engagement scheduled throughout the annual meeting
TRAVEL
In an effort to keep our members safe, we will NOT require approved members to share a room and pay a single room supplement.
Please note below for members who request travel support from AVAHO.
Hotel room will be provided for a single room (up to 3 nights from Thursday to Sunday)
You still have the option to share a room with another attendee
Airfare will be provided up to $500 max. Any excess will be your responsibility.
If you are driving your personal vehicle to Denver, AVAHO will offer .56 cents for mileage (reimbursement for mileage cannot exceed cost of airfare)
You are required to attend the entire program (Friday noon until Sunday noon)
Once your registration has been approved, you will be notified of instructions on next steps (booking airfare, hotel, etc.)
COVID PRECAUTIONS
You will need to sign a COVID release waiver prior to arriving to Denver
If mandated by the hotel, you may be required to wear a mask during AVAHO activities
Practice social distancing when possible
If you are not vaccinated, you are REQUIRED TO WEAR A MASK during AVAHO activities!
Please do not attend if you are experiencing COVID symptoms or currently have COVID
CONTINUING EDUCATION
We will be offering the following continuing education (CE) credits:
ACCME for Physicians
ACPE for Pharmacists
ANCC for Nurses
ASWB for Social Workers
NAACCR for Cancer Registrars
APA for Psychologists
CDR for Dietitians/Nutrition
All others will receive a Certificate of Attendance
If you miss the annual meeting, we will offer CE credits for 1 full year afterwards.
Continuing Education Information
Learner Notification
Association of VA Hematology/Oncology (AVAHO)
9.24.21 Live/Enduring Annual Meeting
Live in Denver, CO September 24 – 26, 2021
Enduring Online October 1, 2021 - October 1, 2022
Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Association of VA Hematology/Oncology (AVAHO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity / enduring material for a maximum of 11.75 live/ 35.75 enduring AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 11.75 live/ 35.75 enduring ANCC contact hours.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 11.75 live/ 35.75 enduring sknowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
Psychologists (APA) Credit Designation
Amedco LLC designates this activity for a maximum of 11.75 live/ 35.75 enduring Psychologist contact hours.
The following state boards accept courses from APA providers for Counselors: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, MD, ME, MO, NC, ND, NH, NE, NJ, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WY
MI: No CE requirements
The following state boards accept courses from APA providers for MFTs: AK, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IN, KS, MD, ME, MO, NE, NC, NH, NJ, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WY
MI: No CE requirement
The following state boards accept courses from APA providers for Addictions Professionals: AK, AR, CO, CT, DC, DE, GA, IA, IN, KS, LA, MD, MO, MT, NC, ND, NE, NJ, NM, NY (outstate held)*, OK, OR, SC, UT, WA, WI, WY
MA / MFTs: Participants can self-submit courses not approved by the MAMFT board for review.
The following state boards accept courses from APA providers for Social Workers: AK, AR, AZ, CA, CO, DE, FL, GA, ID, IN, KY, ME, MN, MO, NE, NH, NM, OR, PA, VT, WI, WY
* If the activity is held live in the state of NY, then direct addictions board is required, ie: NAADAC. If the activity is held outside NY, is virtual, enduring or remote, it is considered "outstate" and this reciprocity applies.
Social Workers (ASWB) Credit Designation
As a Jointly Accredited Organization, Amedco is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Amedco maintains responsibility for this course. Social Workers completing this course receive 11.75 live/ 35.75 enduring GENERAL continuing education credits.
The following state boards accept courses offering ASWB ACE credit for Social Workers: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NC, ND, NE, NH, NM, NV, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WI, WV, WY
* WV accepts ASWB ACE unless activity is live in West Virginia, then an application is required.
The following state boards accept courses offering ASWB ACE credit for Counselors: AK, AR, AZ, CA, CO, CT, DC, FL, GA, IA, ID, IL, IN, KS, MA, MD, ME, MO, ND, NE, NM, NH, NV, OK, OR, PA, TN, TX, UT, VA, WI, WY
AL/Counselors: Activities not providing NBCC approval may be approved by the Board for individual licensees upon receipt of acceptable documentation prior to the activity. Please send course details to your licensing board for approval BEFORE the event. No approvals afterward by the board.
MI: No CE requirement
The following state boards accept courses offering ASWB ACE credit for MFTs: AK, AR, AZ, CA, CO, FL, IA, ID, IN, KS, MD, ME, MO, NC, NE, NH, NM, NV, OK, OR, PA, RI, TN, TX, UT, VA, WI, WY
MA / MFTs: Participants can self-submit courses not approved by the MAMFT board for review.
MI: No CE requirement
The following state boards accept courses offering ASWB ACE credit for Addictions Professionals: AK, CA, CO, CT, GA, IA, IN, KS, LA, MO, MT, ND, NM, NV, OK, OR, SC, WA, WI, WV, WY
Dietitian (CDR) Credit Designation
Amedco LLC designates this activity for a maximum of 11.75 live/ 35.75 enduring CPEU.
NAACCR
The NCRA Program Recognition Committee has determined “2021 Association of VA Hematology/Oncology (AVAHO) Annual Meeting” program supports 35.75 CE hours of which 0 hours meet the Category A requirement. This program has been assigned the following event number: 2021-167.
Objectives - After Attending This Program You Should Be Able To
- Improve understanding of current trends and guidelines in treatment of veterans with cancer and blood disease.
- Develop strategies to enhance comprehensive care delivery (e.g. stewardship) for veterans.
- Recognize how factors, such as equity and diversity, impact care of veterans the veteran with cancer beyond malignancy.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1—6.2, 6.5)
All individuals in a position to control the content of CE are listed below.
| First | Last | Commercial Interest: Relationship |
| Faith | Abodunrin | NA |
| Elizabeth | Agnew | NA |
| Sara | Ahmed | PierianDx: Stock Shareholder |
| Zainub | Ajmal | NA |
| Patrick | Alba | NA |
| Arthur | Allen | Janssen Pharmaceuticals; Alexion Pharmaceuticals: Speakers Bureau, Boehringer-Ingelheim; BMS/Pfizer:Scientific/Medical Advisory Board Member |
| Jennifer | Anderson | NA |
| Lisa | Arfons | NA |
| Tahani | Atieh | NA |
| Alzira | Avelino | NA |
| Yasmine | Ayoub | NA |
| Amin | Azem | NA |
| Megan | Banaszynski | NA |
| Shelby | Banks | NA |
| Megan | Barajas | NA |
| Jill | Bates | NA |
| Srilakshmi | Bathini | NA |
| Margaret | Bauer | NA |
| Julie | Beck | NA |
| Andrew | Benefield | NA |
| Michelle | Bernshteyn | NA |
| Willie | Berry | NA |
| Cindy | Bowman | NA |
| Matthew | Boyer | NA |
| Rachel | Britt | NA |
| Tiniska | Brooks | NA |
| Nicholas | Burwick | NA |
| Nathalie | Byrne | NA |
| Stephanie | Calhoun | NA |
| Arthur | Caplan | WCG: Scientific/Medical Advisory Board Member, Jannsen/J&J: Scientific/Medical Advisory Board Member |
| David | Carpenter | NA |
| Lauren | Caso | NA |
| Nancy | Catalan | NA |
| Stephen | Cernawsky | NA |
| Glen | Cheng | NA |
| Michael | Cheung | NA |
| Alfred | Chicco | NA |
| Wichai | Chinratanalab | NA |
| Gregory | Cichon | NA |
| Khaya | Clark | NA |
| Lauren | Cliffel | NA |
| Alyssa | Cortese | NA |
| Zachary | Creech | NA |
| Grace | Cullen | NA |
| Cheryl | Czerlanis | NA |
| Mary | Dahl | NA |
| Devika | Das | NA |
| Matthew | Derakhshesh | NA |
| Ana | DeVage | NA |
| Morgane | Diven | NA |
| Brian | Do | NA |
| Stacy | Dodd | NA |
| RayeAnn | Dorn | NA |
| Donna | Dunn | NA |
| Oday | Elmanaseer | NA |
| Brian | Engelhardt | NA |
| Dwight | Eplin | NA |
| Laura | Esserman | NA |
| Katherine | Faricy-Anderson | NA |
| January | Fields-Meehan | NA |
| Hava | Fife | NA |
| Warren (Robert) | Floyd | NA |
| Tori | Foote | NA |
| Philip | Foulis | NA |
| Susan | Frayne | NA |
| Nancy | Freeman | NA |
| Daphne | Friedman | NA |
| Valerie | Fristrom | NA |
| Angie | Garinis | NA |
| Isla | Garraway | NA |
| Michael | Gass | NA |
| Darren | Gemoets | NA |
| Mark | Geraci | NA |
| Kristopher | Gerber | NA |
| Joseph | Gibbons | NA |
| Barbara | Gleaton | NA |
| Stacey | Goodman | NA |
| Michael | Goodman | Astellas: Scientific/Medical Advisory Board Member |
| Sara | Gordon | NA |
| Julie | Graff | NA |
| Matthew | Grant | NA |
| Julia | Griffin | NA |
| Anndee | Gritte | NA |
| Aixia | Guo | NA |
| Julia | Hammond | NA |
| Samantha | Hands | NA |
| Deborah | Hartzfeld | NA |
| Haris | Hatic | NA |
| Karice | Haywood | NA |
| Berni | Heron | NA |
| Catherine | Hertz | NA |
| Jim | Hofferkamp | NA |
| Amy | Horowitz | NA |
| Lindsay | Hunter | NA |
| James | Isaacs | NA |
| Dr. Brandi | Jackson | NA |
| Shadia | Jalal | NA |
| Amber | Jimenez | NA |
| Brian | Johnson | NA |
| John | Keighley | NA |
| Michael | Kelley | Regeneron; AstraZeneca; Novartis; Bristol Myers-Squibb; Genentech:Research Grant Overall Principal Investigator; IBM: Other |
| Abdul Moiz | Khan | NA |
| Eugene | Kim | NA |
| Mark | Klein | NA |
| Dawn | Konrad-Martin | NA |
| Courtney | Kovalick | NA |
| Ava | Krmpotich | NA |
| Cecilia | Lacey | NA |
| Robin | Lampton | NA |
| Kelly | Laschinger | NA |
| William | Lee | NA |
| Kyung Min | Lee | NA |
| Brittany | Leneweaver | NA |
| Susan | Lentz | NA |
| Tanja | Lepir | NA |
| Ang | Li | NA |
| Seema | Limaye | NA |
| William | Lorentz | NA |
| Julie | Lynch | NA |
| Fatima | Mahmood | NA |
| Elise | Malecki | NA |
| Rosemarie | Mannino | NA |
| Michael | Masse | NA |
| Sharad | Mathur | NA |
| Kara | Maxwell | NA |
| Lezah | McCarthy | NA |
| William | McKean | NA |
| Kevin | McMahon | NA |
| Gina | McWhirter | NA |
| Syed | Mehdi | NA |
| John | Message | NA |
| Daniel | Mettman | NA |
| Cameron | Miller | NA |
| Cody | Milliman | NA |
| Trisha | Milnes | NA |
| Joseph | Modzelewski | NA |
| Drew | Moghanaki | Varian Medical Systems; Accuray,; ViewRay: Consultant |
| Bruce | Montgomery | AstraZeneca:Research Grant Overall Principal Investigator,Janssen:Research Grant Site Principal Investigator,Beigene:Research Grant Site Principal Investigator,Astellas:Research Grant Site Principal Investigator |
| Demetra | Mylonas | NA |
| Abeeha | Naqvi | NA |
| Divya | Natesan | NA |
| Franklin | Nduku | NA |
| Casey | Nelson | NA |
| Nicholas | Nickols | Oncolinea: Stock Shareholder, Lantheus, Bayer, Janssen: Research Grant Overall Principal Investigator |
| Thomas | Nilles-Melchert | NA |
| Charles | Nock | NA |
| Darryl | Outlaw | NA |
| Inez | Pabian | NA |
| Marcelo | Palmieri | NA |
| Jatinder | Palta | NA |
| Alison | Paolercio | Johnson & Johnson: Speakers Bureau |
| Frank | Paolozzi | NA |
| John | Park | Plexus Communications: Other |
| Prachi | Patel | NA |
| Shawn | Philip | NA |
| Dianne | Piepenburg | NA |
| Rachel | Polaski | NA |
| Michelle | Popadiuk | NA |
| Aarati | Poudel | NA |
| Helene | Powell | NA |
| Colin | Pritchard | AstraZeneca: Consultant |
| Tony | Quang | NA |
| Matthew | Rettig | Amgen, Ambrx, Roivant: Consultant, J&J, Bayer: Speakers Bureau; Merck, Clovis: Research Grant Site Principal Investigator; Progenics: Research Grant Site Principal Investigator, ARavalent: Patent Holder,ARavalent:Corporate Board Member,Suvalent; Oncovalent:Corporate Board Member |
| Lisa | Ritchie | NA |
| Zain | Rizvi | NA |
| Heather | Roderick | NA |
| Thomas | Rodgers | MJH Live Sciences: Consultant |
| Katie | Rogers | NA |
| Lauren | Romanelli | NA |
| Brent | Rose | NA |
| Kerry | Rowe | NA |
| Benjamin | Rush | NA |
| Andrea | Ruskin | NA |
| Ahmad | Sadeghi | NA |
| Rafeh | Safdar | NA |
| Joseph | Salama | AbbVie: Research Grant Overall Principal Investigator, Exact Biosciences: Research Grant Overall Principal Investigator |
| Paloma | Sales | NA |
| Devi | Sampat | NA |
| Bipin | Savani | NA |
| Niramol | Savaraj | NA |
| Maren | Scheuner | NA |
| Jessica | Schmit | NA |
| Sarah | Schultz | NA |
| Janice | Schwartz | NA |
| Jennifer | Selensky | NA |
| Salyka | Sengsayadeth | NA |
| Tracy | Shamas | NA |
| Michael | Shonnard | NA |
| Kendall | Shultes | Oncology Times Author: Other, Projects in Knowledge: Consultant |
| Peter | Silberstein | Bristol Myers : Consultant |
| Alecia | Smalheer | NA |
| Ashley | Snyder | NA |
| Rashna | Soonavala | NA |
| Lucy | Spalluto | NA |
| Laura | Stanko | NA |
| Allison | Stover Fiscalini | NA |
| Leah | Strickland-Marmol | NA |
| Leah | Szumita | NA |
| Peter | Tamba | NA |
| Phillip | Tampis | NA |
| Abubakar | Tauseef | NA |
| Vimala | Thalody | NA |
| Vimala | Thalody | NA |
| Sarah | Theodoroff | NA |
| Mary | Thomas | NA |
| Leann | Ticknor | NA |
| Michelle | Travis DNP | NA |
| Gia Thinh | Truong | NA |
| Chin-Lin | Tseng | NA |
| Fatima | Tuz Zahra | NA |
| Lorene | Valdez-boyle | NA |
| Erin | Valenti | NA |
| Allison | Veide | NA |
| Sierra | Vig | N/A:Other |
| William | Wachsman | Curio Science: Consultant,PRIME Education, LLC: Speakers Bureau, Xcenda/IntrinsiQ: Consultant |
| victor | waters | NA |
| Ali | Wazir | NA |
| Elisa | Weiss | NA |
| Candice | Wenzell | NA |
| Christina | Williams | NA |
| Amanda | Williamson | NA |
| Susie | Willis | NA |
| Jing | Zeng | Gilead Sciences :Research Grant Overall Principal Investigator, AstraZeneca: Scientific/Medical Advisory Board Member, IBA:Consultant, Gilead: Consultant |
| Leah | Zullig | PhRMA Foundation, Proteus Digital Health: Research Grant Overall Principal Investigator; Novartis, Pfizer: Other |
How to Get Your Certificate
- Go to http://AVAHO.cmecertificateonline.com
- Click on the “24.21 Annual Meeting” link.
- Evaluate the meeting.
- Print all pages of your certificate for your records.
Questions? Email Certificate@AmedcoEmail.com